Monocyte deactivation and its reversal in a patient with chemotherapy- induced leukopenia and severe systemic infection

Medical and Pediatric Oncology

Volumn 34, Issue 1, 2000, Pages 39-42

  Bönig, Halvard ^a   Körholz, Dieter ^a   Lex, Christiane ^a   Wölfel, Sonja ^a   Göbel, Ulrich ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Leukopenia; Monocyte deactivation; Neutropenia infection

Indexed keywords

RECOMBINANT GAMMA INTERFERON;

ADOLESCENT; ARTICLE; CASE REPORT; CELL ACTIVATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; LEUKOPENIA; MALE; MONOCYTE; NEUTROPENIA; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; C-REACTIVE PROTEIN; HUMANS; INTERFERON TYPE II; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MONOCYTES; SEPSIS;

EID: 0343986292     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200001)34:1<39::AID-MPO7>3.0.CO;2-3     Document Type: Article

References (14)

1. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation -rationale for a new treatment strategy in sepsis. Intens Care Med 1996;22:S474-S481.
2. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD. Upregulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 1994;7:517-523.
3. Donnelly RP, Freeman SL, Hayes MP. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J Immunol 1995;145:3762-766.
4. Hummel M, Docke WD, Friedel N, von Baehr R, Hetzer R, Volk HD. Monitoring of the cellular immune system in patients with biventricular assist devices awaiting cardiac transplantation. Clin Transplant 1994;8:59-66.
5. Döcke WD, Syrbe U, Meinicke A, et al. Improvement of monoytic function-a new therapeutic approach in sepsis? In: Reinhart K, Eyrich K, Sprung CL, editors. Update in intensive care and emergency medicine. Berlin: Springer: 1994. p 473-488.
6. Westendorp RGJ, Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal menigococcal disease. Lancet 1997;349:170-173.
7. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-1754.
8. Döcke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nature Med 1997;3:678-681.
9. Amluish A, Urba W, Longo D. The determination of an immunologically active dose of interferon-gamma in patients with melanoma. J Clin Oncol 1988;6:434-445.
10. Hempel L, Körholz D, Nußbaum P, Bönig H, Burdach S, Zintl F. High interleukin 10 serum levels are associated with fatal outcome in patients after bone marrow transplantation. Bone Marrow Transplant 1997;20:365-368.
11. Körholz D, Banning U, Bönig H, et al. The role of interleukin-10 (IL-10) in IL-15-mediated T-cell responses. Blood 1997;90:4513-4521.
12. Rutella S, Rumi C, Testa U, et al. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant 1997;20:355-364.
13. Körholz D, Kunst D, Hempel L, et al. Humoral immunodeficiency in patients after bone marrow transplantation. Bone Marrow Transplant 1996;18:1123-1130.
14. Ritter J, Creuzig U, Schellong G. Treatment results of three consecutive German childhood AML trials. Leukemia 1992;6S2:59-62.